SUPPLEMENTAL MEDICAID REBATES WOULD BE PROHIBITED BY HOUSE/SENATE CONFERENCE AGREEMENT ON BUDGET BILL ADOPTED BY HOUSE NOV. 17; NURSING HOMES EXEMPTED
Executive Summary
States would be prohibited from requiring manufacturers to pay supplemental rebates on covered outpatient drugs under a House/Senate conference agreement on the Budget Reconciliation Act (HR 2491).